Evidence map›Paper›PMID 24150258›Full record

ArticleMucosal immunology2014

Immune correlates of HIV exposure without infection in foreskins of men from Rakai, Uganda.

J L Prodger, T Hirbod, G Kigozi, F Nalugoda, S J Reynolds, R Galiwango, K Shahabi, D Serwadda, M J Wawer, R H Gray and 2 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Mucosal immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03412071 (Testing the Ability of a Microbiome - Focused Intervention to Reduce HIV Susceptibility in Ugandan Men), which is not on this map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03412071 naunknown statusnot on this mapstarted 2017, after this paper: background citation

Testing the Ability of a Microbiome - Focused Intervention to Reduce HIV Susceptibility in Ugandan Men

TypeinterventionalSponsorUniversity of TorontoRan2017 to 2019Enrolled125ConditionsForeskin HIV SusceptibilityArmsOral Tinidazole, Topical metronidazole, Topical Clindamycin, Topical Hydrogen Peroxide
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 50 citations in OpenAlex.

  1. Trial
  2. Trial
  3. HIV Transmission and Immunology of the Male Reproductive Tract.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Quantitative Immunofluorescent Imaging of Immune Cells in Mucosal Tissues.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  10. Semen: A modulator of female genital tract inflammation and a vector for HIV-1 transmission.American journal of reproductive immunology (New York, N.Y. : 1989) · 2021
    Review
  11. Article
  12. Review
  13. Betamethasone induces potent immunosuppression and reduces HIV infection in a PBMC in vitro model.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2021
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Impact of Endemic Infections on HIV Susceptibility in Sub-Saharan Africa.Tropical diseases, travel medicine and vaccines · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

J L ProdgerDepartment of Medicine, University of Toronto, Toronto, Ontario, Canada.
T HirbodDepartment of Medicine, Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
G KigoziRakai Health Sciences Program, Kalisizo, Uganda.
F NalugodaRakai Health Sciences Program, Kalisizo, Uganda.
S J Reynolds1] Rakai Health Sciences Program, Kalisizo, Uganda [2] Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA [3] Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
R GaliwangoRakai Health Sciences Program, Kalisizo, Uganda.
K ShahabiDepartment of Medicine, University of Toronto, Toronto, Ontario, Canada.
D Serwadda1] Rakai Health Sciences Program, Kalisizo, Uganda [2] Institute of Public Health, Makerere University, Kampala, Uganda.
M J Wawer1] Rakai Health Sciences Program, Kalisizo, Uganda [2] Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
R H Gray1] Rakai Health Sciences Program, Kalisizo, Uganda [2] Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
R KaulDepartment of Medicine, University of Toronto, Toronto, Ontario, Canada.
Rakai Genital Immunology Research Group
Rakai Health Sciences Program · UGUniversity of Toronto · CAKarolinska Institutet · SEMakerere University · UGNational Institute of Allergy and Infectious Diseases · US

Funding

International Center for Excellence in Research (ICER) in Uganda: Impact of ARVsZIAAI001040 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REYNOLDS, STEVEN · 2009 to 2025
$23.5M
Circumcision: HIV/STIs and behaviors in a RCT and post-RCT surveillance; RakaiU01AI075115 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2007 to 2011
$9.3M
Male Circumcision Trial for HIV Prevention, Rakai-UgandaU01AI051171 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2002 to 2006
$8.9M
Genital Anaerobes, Inflammation and HIV Risk; RakaiR01AI087409 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H, PRICE, LANCE BRADLEY · 2010 to 2012
$2.5M
Male Circumcision and Use of Foreskin Tissues for HIV Prevention in UgandaD43TW009578 · FIC · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2013 to 2017
$1.3M
FIC NIH HHS D43 TW009578Intramural NIH HHSNIAID NIH HHS 1U01AI075115-01A1NIAID NIH HHS R01 AI087409NIAID NIH HHS R01AI087409-01A1NIAID NIH HHS U01 AI051171NIAID NIH HHS U01 AI075115NIAID NIH HHS U01AI51171
6 · The paper itself

Abstract

Human immunodeficiency virus (HIV) susceptibility is heterogenous, with some HIV-exposed but seronegative (HESN) individuals remaining uninfected despite repeated exposure. Previous studies in the cervix have shown that reduced HIV susceptibility may be mediated by immune alterations in the genital mucosa. However, immune correlates of HIV exposure without infection have not been investigated in the foreskin. We collected sub-preputial swabs and foreskin tissue from HESN (n=20) and unexposed control (n=57) men undergoing elective circumcision. Blinded investigators assayed swabs for HIV-neutralizing IgA, innate antimicrobial peptides, and cytokine levels. Functional T-cell subsets from foreskin tissue were assessed by flow cytometry. HESN foreskins had elevated α-defensins (3,027 vs. 1,795 pg ml(-1), P=0.011) and HIV-neutralizing IgA (50.0 vs. 13.5% of men, P=0.019). Foreskin tissue from HESN men contained a higher density of CD3 T cells (151.9 vs. 69.9 cells mm(-2), P=0.018), but a lower proportion of these was Th17 cells (6.12 vs. 8.04% of CD4 T cells, P=0.007), and fewer produced tumor necrosis factor α (TNFα) (34.3 vs. 41.8% of CD4 T cells, P=0.037; 36.9 vs. 45.7% of CD8 T cells, P=0.004). A decrease in the relative abundance of susceptible CD4 T cells and local TNFα production, in combination with HIV-neutralizing IgA and α-defensins, may represent a protective immune milieu at a site of HIV exposure.

Indexed as

AdultAntibodies, NeutralizingCytokinesDisease SusceptibilityFemaleForeskinHIV-1HIV AntibodiesHIV InfectionsHIV SeronegativityHIV SeropositivityHumansImmunity, InnateImmunoglobulin AImmunophenotypingMaleAntibodies, NeutralizingCytokinesHIV AntibodiesImmunoglobulin A

Identifiers

PMID24150258
PMCPMC3997757
OpenAlexW2051176775

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.